Table 3 WHO treatment outcomes by bedaquiline treatment and DR-TB type in MDR-TB patients in South Africa
WHO outcomes, n (%) | MDR N = 3323 | Pre-XDR N = 1246 | XDR N = 1401 | |||
|---|---|---|---|---|---|---|
|  | Bedaquiline N = 1523 | No bedaquiline N = 1800 | Bedaquiline N = 1036 | No bedaquiline N = 210 | Bedaquiline N = 1180 | No bedaquiline N = 221 |
Cured | 778 (51.1) | 753 (41.8) | 515 (49.7) | 49 (23.3) | 641 (54.3) | 48 (21.7) |
Treatment completed | 251 (16.5) | 215 (11.9) | 158 (15.3) | 17 (8.1) | 158 (13.4) | 20 (9.0) |
Died | 205 (13.5) | 385 (21.4) | 148 (14.3) | 82 (39.0) | 224 (19.0) | 105 (47.5) |
Lost to follow-up | 254 (16.7) | 397 (22.1) | 182 (17.6) | 49 (23.3) | 117 (9.9) | 19 (8.6) |
Treatment failed | 35 (2.3) | 50 (2.8) | 33 (3.2) | 13 (6.2) | 40 (3.4) | 29 (13.1) |
Treatment success (cured + treatment completed) | 1029 (67.6) | 968 (53.8) | 673 (65.0) | 66 (31.4) | 799 (67.7) | 68 (30.8) |